astrazeneca stock target: AstraZeneca targets 2024 growth but mixed views hit shares

AstraZeneca expects to boost 2024 revenue and profit on the back of its blockbuster cancer drugs, but lower than expected fourth-quarter profit dragged the London-listed drugmaker’s shares down more t...